By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher today said that its board of directors has authorized a plan to repurchase $750 million of the firm's common stock.

The one-year plan would involve the firm acquiring shares of its common stock on the open market or in negotiated transactions.

Thermo Fisher said that it will offer approximately $750 million of senior notes to refinance outstanding indebtedness.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.